Does DESVENLAFAXINE Cause Neoplasm malignant? 33 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Neoplasm malignant have been filed in association with DESVENLAFAXINE (Desvenlafaxine Succinate). This represents 0.4% of all adverse event reports for DESVENLAFAXINE.
33
Reports of Neoplasm malignant with DESVENLAFAXINE
0.4%
of all DESVENLAFAXINE reports
1
Deaths
1
Hospitalizations
How Dangerous Is Neoplasm malignant From DESVENLAFAXINE?
Of the 33 reports, 1 (3.0%) resulted in death, 1 (3.0%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DESVENLAFAXINE. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does DESVENLAFAXINE Cause?
Drug ineffective (1,576)
Anxiety (679)
Feeling abnormal (671)
Dizziness (605)
Nausea (575)
Headache (548)
Depression (542)
Withdrawal syndrome (530)
Malaise (512)
Insomnia (428)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which DESVENLAFAXINE Alternatives Have Lower Neoplasm malignant Risk?
DESVENLAFAXINE vs DETROL
DESVENLAFAXINE vs DEUCRAVACITINIB
DESVENLAFAXINE vs DEUTETRABENAZINE
DESVENLAFAXINE vs DEUTIVACAFTOR\TEZACAFTOR\VANZACAFTOR
DESVENLAFAXINE vs DEVICE